Data Science in the News

Did you know we have a monthly newsletter? View past volumes and subscribe.

Summer scholar develops data-driven approaches to key NIF diagnostics

Oct. 20, 2021 - 
Su-Ann Chong's summer project, “A Data-Driven Approach Towards NIF Neutron Time-of-Flight Diagnostics Using Machine Learning and Bayesian Inference,” is aimed at presenting a different take on nToF diagnostics. Neutron time-of-flight diagnostics are an essential tool to diagnose the implosion dynamics of inertial confinement fusion experiments at NIF, the world’s largest and most energetic...

Tackling the COVID-19 pandemic

Oct. 11, 2021 - 
To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

60 years of cancer research

Sept. 10, 2021 - 
From studying radioactive isotope effects to better understanding cancer metastasis, the Laboratory’s relationship with cancer research endures some 60 years after it began, with historical precedent underpinning exciting new research areas. In one Cancer Moonshot project, research includes a close synergy between experiments and computation, allowing scientists to get a better picture of the...

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

June 7, 2021 - 
LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

DSI virtual seminar series debuts on YouTube

May 19, 2021 - 
Since launching in 2018, the DSI has hosted more than three dozen speakers in its seminar series. These events invite researchers from academia, industry, and other institutions to discuss their work for an hour to an LLNL audience. In 2020, the series transitioned to a virtual format, and a video playlist of recently recorded seminars is available on the Livermore Lab Events YouTube channel...

Virtual seminar series explores data-driven physical simulations

April 6, 2021 - 
The rapidly growing fields of artificial intelligence (AI) and machine learning (ML) have become cornerstones of LLNL’s data science research activities. The Lab’s scientific community regularly publishes advancements in both AI/ML applications and theory, contributing to international discourse on the possibilities of these compelling technologies. The large volume of AI/ML scientific...

COVID-19 HPC Consortium reflects on past year

April 1, 2021 - 
COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

Ana Kupresanin featured in FOE alumni spotlight

March 10, 2021 - 
LLNL's Ana Kupresanin, deputy director of the Center for Applied Scientific Computing and member of the Data Science Institute council, was recently featured in a Frontiers of Engineering (FOE) alumni spotlight. Kupresanin develops statistical and machine learning models that incorporate real-world variability and probabilistic behavior to quantify uncertainties in engineering and physics...

Model for COVID-19 drug discovery a Gordon Bell finalist

Nov. 17, 2020 - 
A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

From intern to mentor, Nisha Mulakken builds a career in bioinformatics

Nov. 3, 2020 - 
The COVID-19 pandemic has sparked a wave of new research and development at the Lab, and Nisha Mulakken is very busy. The biostatistician has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated...

Advancing healthcare with data science (VIDEO)

Aug. 3, 2020 - 
This video provides an overview of projects in which data scientists work with domain scientists to address major challenges in healthcare. To help fight the COVID-19 pandemic, researchers are developing computer models to search for potential antibody and antiviral drug treatments, sharing a data portal with scientists and the general public, and analyzing drug compounds via a novel text...

Software integration of AI accelerators in HPC (VIDEO)

July 31, 2020 - 
In this episode of Next Platform TV, LLNL's Brian Van Essen talks about AI accelerator integration in HPC systems and software stacks. His interview begins at timestamp 27:57. Watch on YouTube.

Modeling neuronal cultures on 'brain-on-a-chip' devices

June 12, 2020 - 
For the past several years, LLNL scientists and engineers have made significant progress in development of a three-dimensional “brain-on-a-chip” device capable of recording neural activity of human brain cell cultures grown outside the body. The team has developed a statistical model for analyzing the structures of neuronal networks that form among brain cells seeded on in vitro brain-on-a...

Carnegie Live: high energy density science and AI (VIDEO)

June 9, 2020 - 
In this Carnegie Live video, Seiichi Shimasaki, Science Counselor for the Japanese embassy in the U.S., described a multiyear science research program (nicknamed the “Moonshot”) to develop new technologies that help solve some of society’s most pressing challenges. He explained that the Government of Japan was looking for a data science program to mentor young scientists, which led to the...

AI hardware for future HPC systems (VIDEO)

May 20, 2020 - 
This interview with Brian Spears, who leads cognitive simulations at LLNL, covers the current state of evaluation of AI chips and how those will mesh with existing and future HPC systems. Watch on YouTube.

COVID-19 research goes public through new portal

May 18, 2020 - 
A new online data portal is making available to the public a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based “virtual” screening of small molecules and designed antibodies for interactions with the SARS-CoV-2 virus for drug design purposes. The portal houses a wealth of data LLNL scientists have gathered from...

Interpretable AI in healthcare (PODCAST)

May 17, 2020 - 
LLNL's Jay Thiagarajan joins the Data Skeptic podcast to discuss his recent paper "Calibrating Healthcare AI: Towards Reliable and Interpretable Deep Predictive Models." The episode runs 35:50. Listen at Data Skeptic.

Faces of STEM: Brenda Ng (VIDEO)

May 11, 2020 - 
In this video, LLNL machine learning scientist Brenda Ng explains why she loves her job in STEM, what advice she has for others, what inspired her to go into STEM, and what she does in her free time. Watch on YouTube.

The incorporation of machine learning into scientific simulations at LLNL (VIDEO)

May 5, 2020 - 
In this video from the Stanford HPC Conference, Katie Lewis presents "The Incorporation of Machine Learning into Scientific Simulations at Lawrence Livermore National Laboratory." Read more and watch the video at insideHPC.

New ML platform generates novel COVID-19 antibody sequences for experimental testing

May 1, 2020 - 
LLNL researchers have identified an initial set of therapeutic antibody sequences, designed in a few weeks using machine learning and supercomputing, aimed at binding and neutralizing SARS-CoV-2, the virus that causes COVID-19. The research team is performing experimental testing on the chosen antibody designs. Read more at LLNL News.